NFA
NEOS

Nationwide Fund Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Nationwide Fund Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,847
Closed -$108K – 2599
2017
Q3 		$108K Buy
11,847
+1,789
+18% +$13.6K ﹤0.01% 2865
2017
Q2 		$73K Hold
10,058
– – ﹤0.01% 3004
2017
Q1 		$72K Buy
10,058
+1,434
+17% +$8.9K ﹤0.01% 2919
2016
Q4 		$50K Hold
8,624
– – ﹤0.01% 3002
2016
Q3 		$57K Hold
8,624
– – ﹤0.01% 3030
2016
Q2 		$80K Buy
8,624
+5,379
+166% +$51.3K ﹤0.01% 2994
2016
Q1 		$35K Hold
3,245
– – ﹤0.01% 3041
2015
Q4 		$46K Buy
3,245
+2,129
+191% +$32.1K ﹤0.01% 3004
2015
Q3 		$23K Buy
+1,116
New +$24.6K ﹤0.01% 3113

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's NEOS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q4 2017, closing a stake of 11,847 shares — an estimated $108K sold.

Nationwide Fund Advisors first reported a position in NEOS in Q3 2015 and held it in 9 quarters. The position peaked at $108K in Q3 2017. 82 funds tracked by Wall St. Rank hold NEOS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Neos Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 11,847 Neos Therapeutics, Inc shares in Q4 2017, an estimated $108K.
  • Nationwide Fund Advisors first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 9 quarters.
  • Nationwide Fund Advisors's Neos Therapeutics, Inc position peaked at $108K in Q3 2017.
  • 82 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.